AI assistant
SYNLOGIC, INC. — Director's Dealing 2015
Oct 1, 2015
35028_dirs_2015-09-30_ecc20a1a-afe6-422c-a42d-2a38e2b8af1d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Mirna Therapeutics, Inc. (MIRN)
CIK: 0001527599
Period of Report: 2015-09-30
Reporting Person: DeYoung Casi (Chief Business Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $8.10 | 2024-03-10 | Common Stock (49242) | Direct | |
| Stock Option (Right to Buy) | $6.15 | 2025-03-01 | Common Stock (666) | Direct | |
| Stock Option (Right to Buy) | $6.45 | 2025-06-04 | Common Stock (9579) | Direct |
Footnotes
F1: The option vests with respect to 25% of the shares subject thereto on March 10, 2015, with the remaining shares vesting with respect to 1/48 of the total shares subject thereto on each monthly anniversary thereafter, subject to the Reporting Person continuing to provide services to the Issuer through each such vesting date.
F2: The option vests with respect to 25% of the shares subject thereto on January 1, 2016, with the remaining shares vesting with respect to 1/48 of the total shares subject thereto on each monthly anniversary thereafter, subject to the Reporting Person continuing to provide services to the Issuer through each such vesting date.
F3: The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of May 1, 2016, subject to the Reporting Person continuing to provide services to the Issuer through each such vesting date.